Thomas Edward Hamilton, Director at Larimar Therapeutics, Inc. (LRMR), bought 317,460 shares at $3.15 ($1000K) on 2022-09-16, disclosed to the SEC on 2022-09-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| LRMR | BUY | 2024-05-31 | $1000K | — | Filing → |
| LRMR | BUY | 2021-07-02 | $992K | — | Filing → |
| NLY | SELL | 2021-05-04 | $734K | — | Filing → |